Myosin molecular motors play crucial, dynamic roles in most cellular processes, including contraction, movement, and shape change. A variety of diseases owe their origins to defects in myosins. Examples from this family of molecular motors include myosin II, a non-processive motor that drives cytokinesis and muscle contraction, and myosins V and VI, processive motors that drive vesicular movements in neurons and other cell types. Comparative studies of these three family members have revealed key features of how myosins transduce the chemical energy of ATP hydrolysis into the mechanical energy of movement. The molecular basis of myosin function has been analyzed in detail, following the advent of in vitro motility and laser trap assays, the latter of which allows direct measurement of force and displacement produced by a single myosin molecule pulling on a single actin filament. Data from these assays, among others, provide firm evidence supporting the lever arm hypothesis for the origin of directional movement. Nevertheless, many pivotal issues remain. For instance, we are beginning to understand the importance of tension sensing for modulating the activities and functions of myosin motors. In the coming grant period, we will fully characterize the processive stride of myosin VI, the motor that has most challenged conventional views of myosin structure and function. Using functional analyses of monomeric constructs, we will determine the structural basis of the power stroke and diffusive components of the myosin VI processive stride. We will also determine the molecular basis of tension sensing by myosin V and myosin VI and its significance in processivity. This effort will require our single molecule assays to be further developed using the most current available components. Importantly, we will also develop new technologies to directly visualize the power stroke and nucleotide dynamics of myosins in general to rigorously test current models of myosin movement.

Public Health Relevance

All forms of human movement, from the beating of your heart to the processes of individual cell division or cell migration, involve tiny molecular motors that burn the cell's fuel, ATP, in order to produce mechanical force. A wide variety of diseases, including congestive heart failure, cancer, deafness, and a number of neurological syndromes, are the result of defects in these motor proteins. Understanding how they work is therefore fundamental to understanding both their normal and pathologic behaviors.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM033289-27
Application #
7790672
Study Section
Macromolecular Structure and Function C Study Section (MSFC)
Program Officer
Gindhart, Joseph G
Project Start
1984-04-01
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
27
Fiscal Year
2010
Total Cost
$698,018
Indirect Cost
Name
Stanford University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Kawana, Masataka; Sarkar, Saswata S; Sutton, Shirley et al. (2017) Biophysical properties of human ?-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy. Sci Adv 3:e1601959
Gangadharan, Binnu; Sunitha, Margaret S; Mukherjee, Souhrid et al. (2017) Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region. Proc Natl Acad Sci U S A 114:11115-11120
Sung, J; Mortensen, K I; Spudich, J A et al. (2017) How to Measure Load-Dependent Kinetics of Individual Motor Molecules Without a Force-Clamp. Methods Enzymol 582:1-29
Trivedi, Darshan V; Adhikari, Arjun S; Sarkar, Saswata S et al. (2017) Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light. Biophys Rev :
Nag, Suman; Trivedi, Darshan V; Sarkar, Saswata S et al. (2017) The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Nat Struct Mol Biol 24:525-533
Spudich, James A; Aksel, Tural; Bartholomew, Sadie R et al. (2016) Effects of hypertrophic and dilated cardiomyopathy mutations on power output by human ?-cardiac myosin. J Exp Biol 219:161-7
Green, Eric M; Wakimoto, Hiroko; Anderson, Robert L et al. (2016) A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 351:617-21
Manor, Uri; Bartholomew, Sadie; Golani, Gonen et al. (2015) A mitochondria-anchored isoform of the actin-nucleating spire protein regulates mitochondrial division. Elife 4:
Sung, Jongmin; Nag, Suman; Mortensen, Kim I et al. (2015) Harmonic force spectroscopy measures load-dependent kinetics of individual human ?-cardiac myosin molecules. Nat Commun 6:7931
Gupte, Tejas M; Haque, Farah; Gangadharan, Binnu et al. (2015) Mechanistic heterogeneity in contractile properties of ?-tropomyosin (TPM1) mutants associated with inherited cardiomyopathies. J Biol Chem 290:7003-15

Showing the most recent 10 out of 100 publications